Actively Recruiting
Collection of Plasma Samples for Squamous Cell Carcinoma of the Head and Neck Patients
Led by Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Updated on 2023-12-11
400
Participants Needed
5
Research Sites
1039 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigators will collect plasma samples at baseline, during treatment, and at progression.
CONDITIONS
Official Title
Collection of Plasma Samples for Squamous Cell Carcinoma of the Head and Neck Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients treated with radiation therapy and cetuximab according to Bonner et al
- Patients treated with cetuximab in combination with chemotherapy according to Vermorken et al.
- Patients treated with a molecular targeted agent as a part of a clinical study
You will not qualify if you...
- Patients with another type of head and neck cancer
- Patients non treated with targeted therapies
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
Clinique Saint-Pierre
Ottignies, Brabant Wallon, Belgium, 1340
Actively Recruiting
2
Grand Hôpital de Charleroi
Charleroi, Hainaut, Belgium, 6000
Actively Recruiting
3
Centre Hospitalier Jolimont-Lobbes-Nivelles-Tubize
Haine-Saint-Paul, Belgium, 7100
Actively Recruiting
4
CHU Liège
Liège, Belgium, 4000
Actively Recruiting
5
Clinique et Maternité Sainte-Elisabeth
Namur, Belgium, 5000
Actively Recruiting
Research Team
J
Jean-Pascal Machiels, MD, PhD
CONTACT
S
Séverine Carlier, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here